| | A-796260 Basic information |
| Product Name: | A-796260 | | Synonyms: | A-796260;[1-(2-Morpholin-4-ylethyl)-1H-indol-3-yl]-(2,2,3,3-tetraMethylcyclopropyl)Methanone;[1-[2-(4-Morpholinyl)ethyl]-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone;(1-(2-Morpholinoethyl)-1H-indol-3-yl)(2,2,3,3-tetraMethylcyclopropyl)Methanone;[1-(2-morpholin-4-ylethyl)indol-3-yl]-(2,2,3,3-tetramethylcyclopropyl)methanone;Methanone, [1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)- | | CAS: | 895155-26-7 | | MF: | C22H30N2O2 | | MW: | 354.49 | | EINECS: | 806-150-0 | | Product Categories: | Aromatics;Indole Derivatives;Intermediates & Fine Chemicals;Neurochemicals;Pharmaceuticals;Research Chemical | | Mol File: | 895155-26-7.mol |  |
| | A-796260 Chemical Properties |
| Boiling point | 492.7±35.0 °C(Predicted) | | density | 1.16 | | solubility | DMF: 5 mg/ml; DMSO: 3 mg/ml; Ethanol: 5 mg/ml; Ethanol:PBS(pH 7.2) (1:5): 0.16 mg/ml; Methanol: 1 mg/ml | | form | A crystalline solid | | pka | 7.07±0.10(Predicted) |
| | A-796260 Usage And Synthesis |
| Description | A-796260 is a synthetic cannabinoid (CB) that shows high selectivity for the CB2 receptor (Ki = 0.77 nM) over the CB1 receptor (Ki = 2,100 nM). It also shows efficacy in vivo in models of inflammatory, post-operative, neuropathic, and osteoarthritic pain, activities which are selectively blocked by CB2 receptor-selective antagonists. This product is intended for research and forensic uses. | | Uses | A-796,260 is a synthetic cannabinoid that shows high selectivity towards CB2 receptor over the CB1 receptor. A-796,260 showed high efficacy in models of inflammatory, post-operative, neuropathic and OA pain in vivo. |
| | A-796260 Preparation Products And Raw materials |
|